Trials / Completed
CompletedNCT01733810
The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Dallas VA Medical Center · Federal
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the role of hypoxia inducible factor (HIF)-2a on the production of inflammatory cytokines that lead to reflux esophagitis.
Detailed description
Reflux esophagitis is thought to be caused by gastric acid that refluxes into the esophagus, causing injury. Newer data suggest that reflux of gastric juice into the esophagus stimulates HIF-2a, which increases production of inflammatory cytokines. These cytokines are thought to lead to reflux esophagitis. The investigators plan to study the relationship of HIF-2a to inflammatory cytokines in patients with known gastroesophageal reflux disease and reflux esophagitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cessation of Acid Suppressing Medications | Acid-suppressing medications are stopped for all participants the day after baseline assessment. Subsequent evaluations performed while participant is not on acid-suppressing medications. |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2015-07-31
- Completion
- 2019-07-31
- First posted
- 2012-11-27
- Last updated
- 2020-02-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01733810. Inclusion in this directory is not an endorsement.